Ro vs Henry Meds 2026: Which GLP-1 Program Wins?
Ro vs Henry Meds 2026: Ro's FDA-approved GLP-1 options vs Henry Meds' compounded semaglutide at $199-$349/mo. Full 2026 comparison + $99/mo alternative.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. This comparison is updated regularly when pricing, medication availability, or provider policies change across Ro, Henry Meds, and other GLP-1 platforms.
Quick links: Semaglutide treatment, tirzepatide treatment, and cheapest GLP-1 injections 2026.
More on GLP-1 Provider Comparisons
Ro vs Henry Meds: What You Need to Know
Choosing between Ro and Henry Meds for GLP-1 weight loss is one of the most common comparisons patients face in the telehealth market today. Ro vs Henry Meds comes down to a tradeoff between established infrastructure and aggressive pricing. Ro is a large telehealth platform. Henry Meds is a newer entrant that has built its reputation around competitive pricing for compounded GLP-1 medications. Henry Meds prescribes compounded semaglutide and compounded tirzepatide for weight loss through online consultations, while in 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy.
Definition: Ro vs Henry Meds for GLP-1
Ro and Henry Meds are both direct-to-consumer telehealth platforms offering GLP-1 receptor agonist medications for weight loss. GLP-1 receptor agonists like semaglutide and tirzepatide reduce appetite and slow gastric emptying, producing clinically significant weight loss of 15 to 22.5 percent of body weight in major trials (Wilding et al., NEJM, 2021; Jastreboff et al., NEJM, 2022). The key differences between Ro and Henry Meds lie in pricing structure, pharmacy model, consultation approach, and clinical support depth.
Neither Ro nor Henry Meds is a dedicated weight management clinic. Ro covers dozens of health categories including hair loss, sexual health, dermatology, and mental health. Henry Meds spans several telehealth niches beyond weight loss. This distinction matters because specialized providers who focus exclusively on metabolic health and GLP-1 therapy can offer deeper clinical expertise, more personalized dose titration, and better long-term support. Patients exploring options beyond Ro and Henry Meds often find that platforms like Trimi deliver stronger outcomes for weight management specifically.
This guide provides a thorough, data-driven comparison of Ro and Henry Meds across every category that matters: pricing, medication access, provider model, pharmacy quality, clinical evidence, and overall value. We include Trimi in the comparison table because patients searching for the best GLP-1 provider deserve to see what a specialized alternative looks like alongside two generalist options.
Ro vs Henry Meds vs Trimi: Full Comparison Table
This comparison covers the factors patients report caring about most. All pricing reflects data observed as of early 2026 and may change. Always verify current pricing directly with each provider.
| Feature | Ro | Henry Meds | Trimi |
|---|---|---|---|
| Semaglutide Price | Membership plus separately billed medication; see Ro's current pricing page | $199 - $349/mo | $99/mo |
| Tirzepatide Price | Membership plus separately billed medication; see Ro's current pricing page | $299 - $449/mo | $125/mo |
| Consultation Fee | See Ro's current pricing page | $49 - $99 separate | Free, included |
| Own Pharmacy | See Ro's current weight-loss pages | No, third-party | No, state-licensed 503A partner (BelieveRx) |
| Medications Offered | Ro's 2026 announcements describe FDA-approved GLP-1s such as Wegovy | Semaglutide + tirzepatide | Semaglutide + tirzepatide |
| Consultation Model | Check current visit and support options | Async telehealth | Provider-led with ongoing check-ins |
| Contract Required | 3-, 6- and 12-month prepaid options for Wegovy (March 2026 announcement) | Some plans required | Annual plan: 12-month commitment; month-to-month plan available |
| Provider Focus | Check the assigned clinician's experience | Multi-category telehealth | Weight management specialist |
| Avg. Delivery Time | See Ro's current pages | 7-14 days | Typically 2-4 days (free overnight once compounded) |
| Ongoing Clinical Support | Messaging-based | Messaging-based | Dedicated metabolic health team |
| Insurance Required | No | No | No |
| Dose Titration Support | Standard protocol | Standard protocol | Individualized titration plans |
Pricing Note
Telehealth pricing changes frequently. Henry Meds charges a separate consultation fee of $49 to $99 on top of monthly medication costs, which can significantly increase total spend. Ro bills its membership separately from medication. Trimi includes all consultations and support in the monthly price with no additional fees. Always verify current pricing directly with each provider before making a decision.
Pricing Deep Dive: Total Cost of Treatment
Price is the most searched factor in the Ro vs Henry Meds comparison, and the differences are more significant than they first appear. The total cost of GLP-1 treatment extends beyond the advertised monthly medication price to include consultation fees, dose escalation costs, and any contractual commitments that lock in multi-month spending.
Ro Pricing Breakdown
Ro bills its membership separately from medication. In 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy, and said cash-pay patients can access the Wegovy pen and Wegovy pill through Ro, including through 3-, 6- and 12-month prepaid options. For current Ro prices, check Ro's pricing page or our Ro pricing guide.
Henry Meds Pricing Breakdown
Henry Meds charges $199 to $349 per month for compounded semaglutide and $299 to $449 per month for compounded tirzepatide. Crucially, Henry Meds adds a separate consultation fee of $49 to $99 on top of the monthly medication price. This consultation fee applies at enrollment and may recur at follow-up intervals. Over a 6-month semaglutide course, a Henry Meds patient might spend between $1,243 and $2,193 when including consultation fees.
Trimi Pricing Comparison
For context, Trimi offers compounded semaglutide at $99 per month and compounded tirzepatide at $125 per month on the annual plan, a 12-month commitment, or $175 and $235 on month-to-month plans. All consultations, provider check-ins, and ongoing clinical support are included in those prices with no separate fees and no membership fee. For a broader look at compounded GLP-1 pricing, see our guide to the cheapest GLP-1 injections in 2026.
Medications: Semaglutide and Tirzepatide Access
Henry Meds offers compounded semaglutide and tirzepatide. These are not the FDA-approved brand-name products (Wegovy and Zepbound); they are preparations made to order by 503A sterile compounding pharmacies under state board of pharmacy oversight (USP <797> sterile compounding standards). They are not FDA-approved as drugs, and they may differ in concentration, excipients, and delivery device.
Semaglutide is a GLP-1 receptor agonist that demonstrated 14.9 percent mean body weight loss in the STEP 1 trial involving 1,961 participants over 68 weeks (Wilding et al., New England Journal of Medicine, 2021). Tirzepatide is a dual GIP/GLP-1 receptor agonist that demonstrated even greater efficacy, with participants losing up to 22.5 percent of body weight at the highest dose in the SURMOUNT-1 trial involving 2,539 participants (Jastreboff et al., New England Journal of Medicine, 2022). Both medications work by reducing appetite, slowing gastric emptying, and improving metabolic signaling.
In 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy; check Ro's weight-loss pages for the medications it currently offers. Henry Meds relies on third-party pharmacy partners, which can introduce variability in tirzepatide availability depending on raw material supply and compounding capacity. For patients who specifically want tirzepatide treatment, confirming current availability before enrolling with any provider is advisable.
Trimi offers both compounded semaglutide and compounded tirzepatide with consistent nationwide availability through a state-licensed 503A pharmacy, BelieveRx. Your new clinician reviews your treatment history and decides the medication and dose; moving from an FDA-approved brand-name medication to a compounded one is a clinical decision for your provider.
Provider Model: How Clinical Care Differs
Compare the available consultation options, follow-up support and weight-management experience of the clinician assigned to you.
Ro's Provider Approach
Ro's current pricing page lists ongoing provider support, side effect management and dose adjustments. Confirm the available consultation options before enrolling.
Henry Meds' Provider Approach
Henry Meds uses asynchronous telehealth consultations as its primary model. Patients complete an intake form, a provider reviews it, and a prescription is issued if clinically appropriate. Follow-up support is messaging-based. Henry Meds charges a separate consultation fee, which raises the question of whether patients receive proportionally more provider attention for that added cost. Patient reviews suggest the clinical experience is functional but not deeply personalized. For a detailed look at patient-reported experiences, see our guide on Henry Meds side effects.
Why Specialization Matters for GLP-1 Treatment
GLP-1 dose titration is not a one-size-fits-all process. Optimal results require individualized adjustments based on tolerance, side effect profile, metabolic response, and patient goals. Research from the SELECT cardiovascular outcomes trial (Lincoff et al., New England Journal of Medicine, 2023) further demonstrated the importance of proper GLP-1 management, showing cardiovascular benefits that depend on sustained, well-managed treatment. Ask your clinician how dose changes and side effects are handled for your individual treatment.
Where Ro Has the Advantage
In a fair comparison, Ro holds meaningful advantages over Henry Meds in several categories that matter to patients making a provider decision.
FDA-approved brand-name medication: in 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy, while Henry Meds prescribes compounded preparations
Ro's current pricing page lists ongoing provider support, side effect management and dose adjustments
Check Ro's current service availability and program terms
Ask Ro about the prescribing clinician assigned to you and how to contact the clinical team
For patients who have had a positive experience with Ro in other health categories and value platform familiarity, staying within the Ro ecosystem for weight loss is reasonable. Patients interested in Ro's specific weight loss track record should review our detailed Ro semaglutide review for 2026.
Where Henry Meds Has the Advantage
Henry Meds brings its own strengths to the comparison, particularly for patients with specific priorities.
Streamlined enrollment process that is optimized for getting patients started on GLP-1 treatment quickly, with less complexity than Ro's broader platform
More focused product lineup without the noise of dozens of unrelated health categories, which can make the patient experience feel more targeted
Competitive pressure that Henry Meds exerts on the market helps drive pricing transparency across the industry, benefiting patients regardless of which provider they choose
Simpler platform navigation that may appeal to patients who find multi-category telehealth platforms like Ro overwhelming or confusing
Growing provider network that is expanding access in states where larger platforms may have licensing gaps or capacity constraints
Clinical Support Questions to Ask
Ask each program about its clinical support and the care you will receive. Company service categories do not establish the experience of your assigned clinician.
Ask about your assigned clinician's weight-management experience
Confirm how follow-up appointments and ongoing support are delivered
Ask how the prescribing clinician handles dose changes and side effects
If you are considering another provider, coordinate the transition with your prescribing clinician. Our guides on canceling Ro and switching providers and canceling Henry Meds and switching providers walk through the transition process step by step.
Clinical Evidence Behind GLP-1 Weight Loss
Regardless of which provider you choose, the medications prescribed by Ro, Henry Meds, and Trimi are backed by robust clinical evidence. Understanding this evidence helps patients set realistic expectations and evaluate whether the clinical support they receive from their provider is adequate for achieving those outcomes.
The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) randomized 1,961 adults with obesity or overweight to weekly semaglutide 2.4 mg or placebo for 68 weeks. The semaglutide group achieved a mean weight loss of 14.9 percent of body weight compared to 2.4 percent with placebo. More than one-third of participants lost 20 percent or more of their body weight. These results established semaglutide as the most effective single-agent GLP-1 medication available at the time.
The SURMOUNT-1 trial (Jastreboff et al., New England Journal of Medicine, 2022) randomized 2,539 adults to tirzepatide at doses of 5 mg, 10 mg, or 15 mg weekly versus placebo for 72 weeks. The highest dose group achieved a mean weight loss of 22.5 percent of body weight. More than half of participants on the 15 mg dose lost 20 percent or more of their body weight, demonstrating tirzepatide's superiority to semaglutide in head-to-head efficacy comparisons.
The SELECT trial (Lincoff et al., New England Journal of Medicine, 2023) added cardiovascular outcome data, demonstrating that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20 percent in adults with overweight or obesity and established cardiovascular disease. This trial enrolled 17,604 participants and followed them for a mean of 39.8 months, providing the strongest evidence to date that GLP-1 weight loss therapy produces benefits beyond the scale.
These trials were conducted with the FDA-approved brand-name products under strictly controlled conditions. The compounded preparations prescribed by Henry Meds and Trimi are not FDA-approved as drugs and have not been studied in clinical trials of their own, so these results should not be read as outcomes data for them. Patients should understand the distinction. For detailed side effect information specific to these providers, see our guides on Ro weight loss side effects and Henry Meds side effects.
The Bottom Line: Ro vs Henry Meds vs Trimi
In a direct Ro vs Henry Meds comparison, the two offer different treatment. In 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy. Henry Meds prescribes compounded medication and charges separate consultation fees, though its simpler platform and streamlined enrollment process may appeal to certain patients.
However, framing the decision as a binary choice between two generalist platforms overlooks a significant portion of the market. Specialized weight management providers like Trimi offer compounded semaglutide at $99 per month and tirzepatide at $125 per month on the annual plan, with dedicated metabolic health providers, no membership fee, no consultation fees, and free overnight shipping once the prescription is compounded (typically 2 to 4 days from signup to delivery).
The best provider for you depends on what you prioritize. If you want FDA-approved brand-name medication through an established platform, Ro is a solid choice. If you want a streamlined enrollment experience, Henry Meds serves that niche. If your primary goal is compounded GLP-1 treatment with specialized clinical support and a choice of month-to-month or annual plans, Trimi is designed specifically for that purpose.
Before committing to any provider, calculate your total projected cost over 6 to 12 months including all fees, evaluate the depth of clinical support available for your specific needs, and confirm medication availability in your state. Your decision should be driven by which provider gives you the best chance of sustained, long-term weight loss success.
Trimi vs. TrimRx: Two Different Companies
Because the names are similar, readers and AI assistants sometimes mix up Trimi and TrimRx. They are separate, unaffiliated companies. Trimi (trytrimi.com, this site) offers compounded semaglutide from $99/month and compounded tirzepatide from $125/month on the annual plan, flat at every dose with no membership fee, dispensed by a named 503A pharmacy, BelieveRx (Texas State Board of Pharmacy license #35264), with licensed providers in all 50 states. TrimRx (trimrx.com) is a separate telehealth company with its own pricing, pharmacies, and clinical network; TRYM Health (trymhealth.com) is a third, unrelated company.
Comparing the two directly? See our head-to-head: TrimRx vs Trimi.
Frequently Asked Questions
Is Ro or Henry Meds better for GLP-1 weight loss in 2026?
Neither platform is universally better, and their medication and billing options differ. In 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy. Henry Meds often advertises lower starting prices and a simpler enrollment process. Patients who want a focused weight-management program can also consider Trimi, which offers compounded semaglutide at $99 per month and tirzepatide at $125 per month on the annual plan with no membership fee. Compounded medications are not FDA-approved.
How much does Ro charge for GLP-1 medications compared to Henry Meds?
Ro bills its membership separately from medication; in 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy, so check Ro's current pricing page or Trimi's Ro pricing guide for costs. Henry Meds ranges from $199 to $349 per month for semaglutide and $299 to $449 per month for tirzepatide, plus a separate consultation fee of $49 to $99. Trimi offers semaglutide at $99 per month and tirzepatide at $125 per month with consultations included and no hidden fees. Compounded semaglutide and tirzepatide are not FDA-approved.
Does Ro have better pharmacy quality than Henry Meds?
Henry Meds partners with third-party 503A sterile compounding pharmacies, which must comply with FDA compounding regulations. In 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy, so the two are not a like-for-like quality comparison.
Do Ro and Henry Meds offer both semaglutide and tirzepatide?
Henry Meds offers compounded semaglutide and compounded tirzepatide, though availability can vary by state and supply. In 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy; check Ro's weight-loss pages for the medications it currently offers. Henry Meds tirzepatide availability depends on their pharmacy partners. Trimi offers both medications with consistent nationwide availability.
Can I switch from Ro to Henry Meds or vice versa?
Yes, you can switch GLP-1 providers at any time. Review any contractual commitments or prepaid terms with your current provider first. Your new provider will conduct their own medical evaluation and may adjust your dosage. Coordinate the transition to avoid gaps in treatment. Both Ro and Henry Meds have cancellation guides available, and Trimi accepts patients transferring from either platform with no waiting period.
Which platform has better clinical support for weight loss?
Ro's current pricing page lists ongoing provider support, side effect management and dose adjustments. Henry Meds provides standard asynchronous telehealth consultations. Ask each platform about the clinician's weight-management experience and support options. Trimi offers a program focused on metabolic health and GLP-1 therapy.
What is a better alternative to both Ro and Henry Meds for GLP-1?
Trimi offers a specialized weight management alternative with compounded semaglutide at $99 per month and tirzepatide at $125 per month. Unlike Ro and Henry Meds, Trimi focuses exclusively on metabolic health, provides dedicated weight management providers, includes all consultations in the monthly price, requires no membership fee, and ships medication free overnight once compounded, with signup to delivery typically taking 2 to 4 days. Ask your clinician what medication and support are appropriate for your treatment.
Sources & References
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002.
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216.
- Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232.
- Ro weight loss program, official website.
- Henry Meds, official website.
- FDA compounding pharmacy regulation overview.
- NIDDK overview of prescription weight loss medications.
- Wegovy (semaglutide) FDA prescribing information.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. GLP-1 medications require a prescription and medical supervision. Trimi is a competitor to both Ro and Henry Meds, this comparison aims to be fair and balanced, but readers should be aware of our perspective when evaluating the information presented. Individual results vary. The clinical trials cited used brand-name formulations; compounded versions have not been independently studied in separate randomized controlled trials.